Evaluation of Lamivudine Resistance Mutations in HBV/HIV Co-infected Patients

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 80

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJMM-16-1_007

تاریخ نمایه سازی: 27 بهمن 1400

Abstract:

Background and Objective: The drug resistance mutations are key elements in the failure of long-term treatment of Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections. The mutation in the YMDD motif in the P gene of HBV is the most critical factor in antiviral drug (especially lamivudine) resistance. This study aimed to assess the YMDD motif and other polymerase gene mutations in individuals with HBV/HIV coinfection. Materials and Methods: All enrolled patients were under lamivudine treatment. Blood samples were collected from ۳۷ HBV/HIV-positive patients, and DNA was extracted. The P gene was amplified by the PCR method with appropriate primers. The PCR products for detecting mutations in the P gene were sent to the Macrogen. To investigate the P gene mutations, the obtained sequences were compared with the polymerase gene of the HBV standard sequence in the GeneBank (accession number AB۰۳۳۵۵۹). Results: The mean age of the patients was ۳۴.۱±۵.۷ years, of which ۵۹.۵% were male, and ۴۰.۵% were female. Of all patients, ۵۶% were drug abusers, ۳۵% had risky sexual behavior, ۵۶% had prison history, and ۳۳% had addicted wives. The ۳۷ extracted samples were sequenced successfully. Among the studied samples (n =۳۷), ۲۸ patients had simultaneous mutations of YIDD and FLMAQ, ۱ patient had YINN and FLIPH and ۱ patient had YIDD and FSLAQ. Conclusion: In summary, drug-resistant variants were detectable in most coinfected patients with chronic Hepatitis B (CHB) and HIV. As a result of mutations, therapeutic strategies sometimes are not effective. Therefore, recognition and monitoring of drug resistance mutations are critical.

Authors

Fatemeh Dolati

Department of Microbiology, Damqan University of Medical Sciences, Damqan, Iran

Emad Behboudi

Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran

Malihe Naderi

Infectious Disease Research Center, Golestan University of Medical Sciences, Gorgan, Iran

Iraj Shahramian

Department of Pediatric, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran

Abdolvahab Moradi

Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Ribeiro CRA, de Almeida NAA, Martinelli KG, et al. Cytokine ...
  • Ireland G, Simmons R, Balogun K, Kirwan P, Sabin CA, ...
  • Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, ...
  • Rajbhandari R, Jun T, Khalili H, Chung RT, Ananthakrishnan AN. ...
  • Hanazaki K. Antiviral therapy for chronic hepatitis B: a review; ...
  • Lavanchy D, Kane M. Global epidemiology of hepatitis B virus ...
  • Maucort‐Boulch D, de Martel C, Franceschi S, Plummer MJIjoc. Fraction ...
  • Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, ...
  • Alter H, Block T, Brown N, Brownstein A, Brosgart C, ...
  • Pappoe, F., Hagan, C.K.O., Obiri-Yeboah, D. Sero-prevalence of hepatitis B ...
  • Liaw Y-F, Sung JJ, Chow WC, Farrell G, Lee C-Z, ...
  • Feng B, Wei L, Chen M, Wang LJMr. Dynamic changes ...
  • Liu KZ, Hou W, Zumbika E, Ni Q. Clinical features ...
  • Bennet JE, Blaser MJ, Dolin R. Principles and practice of ...
  • Lee CZ, Lee HS, Huang GT, Yang PM, Sheu JC. ...
  • Karami C, H Adli A, Zhand S, Tabarraei A, Talei ...
  • Kobayashi S, Ide T, Sata MJJoh. Detection of YMDD motif ...
  • Zhang X, Zhang Y, Sun L, Wen Q, Zhou L, ...
  • Yan M, Zhang C, Ling Q, Zhou RF. Detection of ...
  • Cuestas ML, Mathet VL, Oubiña JR, Sosnik AJPr. Drug delivery ...
  • Lin C, Tsai S, Lee T-H, Chien R, Liao S, ...
  • Kobayashi M, Suzuki F, Akuta N, Yatsuji H, Hosaka T, ...
  • Zoulim F, Poynard T, Degos F, Slama A, El Hasnaoui ...
  • Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, ...
  • Lo CM, Liu CL, Lau GK, Chan SC, Ng IO, ...
  • Inoue J, Ueno Y, Wakui Y, Niitsuma H, Fukushima K, ...
  • Bozdayi A, Uzunalimoǧlu Ö, Türkyilmaz A, Cinar K, Sezgin O, ...
  • https://doi.org/۱۰.۱۰۱۶/S۰۱۶۸-۸۲۷۸(۰۱)۸۰۵۹۴-۸Delaney IV WE, Locarnini S, Shaw TJAC, Chemotherapy. Resistance of ...
  • Yıldız O, Aygen B, Demirtürk N, Demirdal T, Inan D, ...
  • Arrese E, Basaras M, Blanco S, Ruiz P, Cisterna R. ...
  • Kim J-K, Lee H-J, Lee Y-J, Chun J-Y, Lee I-K, ...
  • Tamandjou Tchuem CR, Brandt L, Nel EDlR, Cotton MF, Matthews ...
  • Wang C, Yu S, Zhang Y, Zhang M, Lv L, ...
  • Horgan M, Brannigan E, Crowley B, Levis J, Fanning LJ. ...
  • Thio CL, Locarnini SJAr. Treatment of HIV/HBV coinfection: clinical and ...
  • Mirandola S, Campagnolo D, Bortoletto G, Franceschini L, Marcolongo M, ...
  • نمایش کامل مراجع